BIO-RAD LABORATORIES, INC. Net Cash Provided by (Used in) Financing Activities in USD from Q1 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Bio Rad Laboratories, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2010 to Q1 2025.
  • Bio Rad Laboratories, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was -$97.7M.
  • Bio Rad Laboratories, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was -$219M, a 48.6% increase from 2023.
  • Bio Rad Laboratories, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$426M, a 144% decline from 2022.
  • Bio Rad Laboratories, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $974M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

BIO-RAD LABORATORIES, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 -$97.7M -$97.7M Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-01
Q1 2024 $0 -$4.31M -100% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-01
Q1 2023 $4.31M -$1.19B -99.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q1 2022 $1.19B +$1.24B Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q1 2021 -$47.3M +$51.3M +52% Jan 1, 2021 Mar 31, 2021 10-Q 2022-04-29
Q1 2020 -$98.6M -$101M -4663% Jan 1, 2020 Mar 31, 2020 10-Q 2021-04-30
Q1 2019 $2.16M -$354K -14.1% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 $2.52M +$1.84M +274% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $673K +$415K +161% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2016 $258K +$589K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q1 2015 -$331K -$3.82M -109% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q1 2014 $3.49M +$10.9M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-06
Q1 2013 -$7.43M -$11.1M -300% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-08
Q1 2012 $3.72M +$218M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q1 2011 -$215M -$216M -20888% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-10
Q1 2010 $1.03M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-06

BIO-RAD LABORATORIES, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$219M +$207M +48.6% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-14
2023 -$426M -$1.4B -144% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-14
2022 $974M +$1.03B Jan 1, 2022 Dec 31, 2022 10-K 2025-02-14
2021 -$55.4M +$468M +89.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 -$523M -$500M -2198% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 -$22.8M +$25.9M +53.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-11
2018 -$48.7M -$49M -14376% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-16
2017 $341K -$8.68M -96.2% Jan 1, 2017 Dec 31, 2017 10-K 2020-03-02
2016 $9.02M +$439K +5.12% Jan 1, 2016 Dec 31, 2016 10-K 2019-04-01
2015 $8.58M -$3.11M -26.6% Jan 1, 2015 Dec 31, 2015 10-K 2018-04-16
2014 $11.7M +$323M Jan 1, 2014 Dec 31, 2014 10-K 2017-03-01
2013 -$312M -$324M -2576% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-29
2012 $12.6M +$226M Jan 1, 2012 Dec 31, 2012 10-K 2015-03-02
2011 -$214M -$442M -193% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-18
2010 $229M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.